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A 60-year-old woman presented with a distinct, sharply 
demarcated plaque on her left flank. The plaque measured 
approximately 8 cm in diameter and consisted of confluent, 
brownish-erythematous dome-shaped papules, with a parti-
ally verrucous surface (Fig. 1A). In addition, she reported 
a subcutaneous nodule on the left upper arm. The lesions 
first appeared 4 months earlier with mild itching and pain. 
Physical examination revealed no further involvement of the 
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Fig. 1. (A) Sharply demarcated plaque on the left flank, consisting of confluent, brownish-erythematous dome-shaped papules, with a partially verrucous 
surface. (B) Haematoxylin and eosin (H&E) staining with dense dermal infiltrate of histiocytes admixed with inflammatory cells: plasma cells, lymphocytes 
and eosinophils (original magnification ×2). (C) Aggregates of large histiocytes with slightly eosinophilic cytoplasm containing inflammatory cells within 
their cytoplasm: emperipolesis (original magnification ×40).
skin or palpable lymph nodes. Beside arterial hypertension 
and a dyslipidaemia, her medical history, familial medical 
history and routine laboratory tests were unremarkable. A 
punch biopsy specimen from the lesion on the flank and 
an excision biopsy of the nodule on the upper arm were 
obtained. 
What is your diagnosis? See next page for answer.
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ANSWERS TO QUIZ
Dome-shaped Papules on the Left Flank: A 
Commentary
Acta Derm Venereol 2017; 97: xx–xx.
Diagnosis: Cutaneous Rosai-Dorfman Disease (sinus 
histiocytosis with massive lymphadenopathy)
Biopsy specimens revealed a dense dermal infiltrate con-
sisting of histiocytes admixed with inflammatory cells: 
plasma cells, lymphocytes and eosinophils (Fig. 1B). 
Emperipolesis, which is a process of engulfment of viable 
inflammatory cells by histiocytes, could be detected (Fig. 
1C). Immunohistochemistry showed co-expression of S100 
and CD68 in the histiocytic cells, whereas CD1a remained 
negative. The 18F-fluoro-2-deoxy-D-glucose (18F-FDG) po-
sitron emission tomography/computed tomography (PET/
CT) did not detect lymph node involvement or extranodal 
manifestation of Rosai-Dorman disease (RDD).
RDD, also known as sinus histiocytosis with massive 
lymphadenopathy, is a rare, self-limiting histiocytic disorder 
of unknown aetiology (1). The polyclonality of the cellular 
infiltrate in RDD suggests that the disease has a reactive 
rather than a neoplastic nature. Abnormal response to anti-
genic stimuli may be related to RDD; circulating antibodies 
to Borrelia, human herpes virus 6, and Epstein-Barr virus 
have been detected in some patients (2). RDD is typically 
characterized by lymphadenopathy (especially bilateral 
cervical lymphadenopathy), fever and weight loss, leuko-
cytosis, polyclonal gammopathy, anaemia, and elevated 
erythrocyte sedimentation rate. Extranodal lesions occur 
in approximately one-third, and the skin has been involved 
in > 10% of reported cases. RDD limited to the skin only is 
rare, with < 100 cases reported until now (3). 
The histological features of RDD in the lymph nodes 
are characteristic, and include expansion of the sinuses by 
large foamy histiocytes admixed with plasma cells. Cuta-
neous lesions show a dense dermal infiltrate of polygonal 
histiocytes with abundant pale cytoplasm, large nuclei 
with dispersed chromatin and prominent nucleoli. The skin 
infiltrate is admixed with inflammatory cells: plasma cells, 
lymphocytes and eosinophils (1). The enlarged histiocytes 
stain positive for CD68 and S100 and are negative for 
CD1a (2). Emperipolesis, which is a process of engulf-
ment of inflammatory cells, protected from degradation 
by intracytoplasmatic vacuoles within the cytoplasm of 
the histiocytes, is a hallmark feature of RDD. Emperi-
polesis can be also observed in other haematological and 
non-haematological conditions, such as leukaemia, and 
multiple myeloma (4).
Treatment approaches for RDD depend on the nodal or 
extranodal manifestation of the disease and the clinical 
symptoms. As spontaneous resolution has been reported, 
“wait and see” is an option for patients with uncomplicated 
lymph node involvement or asymptomatic cutaneous RDD. 
Surgical excision, radiotherapy and systemic corticosteroids 
have been used with some success. In the case presented 
here, radiotherapy to a total cumulative dose of 32 Gray 
did not result in a clinical response. As a second-line line 
approach it was decided to use class IV topical steroids, 
and this treatment is currently ongoing. If topical steroids 
are also ineffective, either surgical excision or “watchful 
waiting” will be proposed to the patient. There are scatte-
red reports on the use of thalidomide, imatinib, rituximab, 
oral 6-mercaptopurine and methotrexate for patients with 
refractory RDD (5–7). Clofarabine and cladribine have 
been applied in patients with relapsed, multisystem, non-
resectable central nervous system (CNS) or autoimmune-
related RDD (8).
REFERENCES
1. Brenn T, Calonje E, Granter SR, Leonard N, Grayson W, 
Fletcher CD, McKee PH. Cutaneous Rosai-Dorfman disease 
is a distinct clinical entity. Am J Dermatopathol 2002; 24: 
385–391.
2. Elbuluk N, Egbers R, Taube JM, Wang TS. Cutaneous Rosai-
Dorfman disease in a patient with human immunodeficiency 
virus. Dermatol Online J 2016; 22. pii: 13030/qt2162h3fj.
3. Kong YY, Kong JC, Shi DR, Lu HF, Zhu XZ, Wang J, Chen ZW. 
Cutaneous rosai-dorfman disease: a clinical and histopat-
hologic study of 25 cases in China. Am J Surg Pathol 2007; 
31: 341–350.
4. Rastogi V, Sharma R, Misra SR, Yadav L, Sharma V. Empe-
ripolesis – a review. J Clin Diagn Res 2014; 8: ZM01–02.
5. Sun NZ, Galvin J, Cooper KD. Cutaneous Rosai-Dorfman 
disease successfully treated with low-dose methotrexate. 
JAMA Dermatol 2014; 150: 787–788.
6. Li X, Hong Y, An Q, Chen J, Wei H, Chen HD, Gao XH. Suc-
cessful treatment of Rosai-Dorfman disease with low-dose 
oral thalidomide. JAMA Dermatol 2013; 149: 992–993.
7. Nadal M, Kervarrec T, Machet MC, Petrella T, Machet L. Cu-
taneous Rosai-Dorfman disease located on the breast: rapid 
effectiveness of methotrexate after failure of topical corti-
costeroids, acitretin and thalidomide. Acta Derm Venereol 
2015; 95: 758–759.
8. Haroche J, Cohen-Aubart F, Rollins BJ, Donadieu J, Charlotte 
F, Idbaih A, et al. Histiocytoses: emerging neoplasia behind 
inflammation. Lancet Oncol 2017; 18: e113–e125.
